4
Changes in Ownership
ATOSSA THERAPEUTICS, INC. Filed Acc 0001552127-14-000001
Options or other derivatives
- Chief Scientific Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Chen Shu-Chih Chief Scientific Officer | 2014-05-06 | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…